Becton Dickinson (BDX) Other Non-Current Liabilities (2009 - 2026)
Becton Dickinson (BDX) posted quarterly Other Non-Current Liabilities of $2.5 billion for Q1 2026, down 17.95% year-over-year from $3.0 billion in Q1 2025, and down 12.61% quarter-over-quarter from $2.8 billion in Q4 2025.
Becton Dickinson (BDX) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has reported Other Non-Current Liabilities for 18 consecutive years, with $2.5 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Liabilities fell 17.95% year-over-year to $2.5 billion; the TTM figure through Mar 2026 stood at $2.5 billion (down 17.95% YoY), while the FY2025 annual figure was $2.6 billion, down 26.03% from the prior year.
- Other Non-Current Liabilities declined to $2.5 billion in Q1 2026 per BDX's latest filing, from $2.8 billion in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $5.1 billion in Q3 2022 and bottomed at $2.5 billion in Q1 2026.
- Historically, Other Non-Current Liabilities has averaged $3.9 billion across 5 years, with a median of $4.3 billion in 2024.
- Annual changes were most pronounced in 2022 — Other Non-Current Liabilities fell 3.01% — and 2025, when it plunged 30.46%.
- Becton Dickinson's Other Non-Current Liabilities stood at $4.9 billion in 2022, then fell by 9.21% to $4.4 billion in 2023, then dropped by 22.56% to $3.4 billion in 2024, then dropped by 17.64% to $2.8 billion in 2025, then declined by 12.61% to $2.5 billion in 2026.
- Business Quant data shows BDX's Other Non-Current Liabilities at $2.5 billion in Q1 2026, $2.8 billion in Q4 2025, and $2.6 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.39 Bn |
| Mar 31, 2026 | 2.46 Bn |
| Dec 31, 2025 | 2.82 Bn |
| Sep 30, 2025 | 2.63 Bn |
| Jun 30, 2025 | 2.83 Bn |
| Mar 31, 2025 | 3.00 Bn |
| Dec 31, 2024 | 3.42 Bn |
| Sep 30, 2024 | 3.56 Bn |
| Jun 30, 2024 | 4.07 Bn |
| Mar 31, 2024 | 4.30 Bn |
| Dec 31, 2023 | 4.41 Bn |
| Sep 30, 2023 | 4.58 Bn |
| Jun 30, 2023 | 4.37 Bn |
| Mar 31, 2023 | 4.47 Bn |
| Dec 31, 2022 | 4.86 Bn |
| Sep 30, 2022 | 5.05 Bn |
| Jun 30, 2022 | 4.93 Bn |
| Mar 31, 2022 | 4.97 Bn |
| Dec 31, 2021 | 5.03 Bn |
| Sep 30, 2021 | 5.21 Bn |